Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to assess the safety and efficacy of HANBIO BarriGel to prevent thyroidectomy postoperative adhesions


Clinical Trial Description

The objective of this study is to evaluate the efficacy of HANBIO BarriGel in the prevention of postoperative adhesion for patients who will undergo open thyroidectomy. The dysphagia and adhesion severity will be assessed at specific visits pre and/or post-operation for both treatment group and control group. The post-operative condition, and the adverse event information will be collected for evaluation of tolerability and safety of the product. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05036525
Study type Interventional
Source HAN Biomedical Inc
Contact Wen Lin Wu
Phone 886-2-26971328
Email [email protected]
Status Not yet recruiting
Phase N/A
Start date September 2021
Completion date June 2023

See also
  Status Clinical Trial Phase
Recruiting NCT04589884 - Intraoperative EXamination Using MAChine-learning-based HYperspectral for diagNosis & Autonomous Anatomy Assessment
Completed NCT00569920 - Nausea and Pain Prophylaxis During Thyroid Surgery N/A
Not yet recruiting NCT04040673 - RAman For Thyroid cancER
Recruiting NCT04704349 - Latest Imaging SPECT System Evaluation Phase 1 N/A
Completed NCT01727973 - Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy Phase 1/Phase 2
Not yet recruiting NCT04094493 - Vit D Role in Post Thyroidectomy Hypocalcemia Early Phase 1
Completed NCT03157466 - Respiratory Muscle Function After Thyroid Hormone Replacement Therapy in Nonthyroidal Illness Syndrome
Recruiting NCT04542278 - Preoperative Steroids in Autoimmune Thyroid Disease Phase 4
Completed NCT04425512 - Delta Neutrophil Index and Neutrophil Lymphocyte Ratio in Thyroid Malignancy N/A
Not yet recruiting NCT04873531 - Feasibility of Neostigmine for Intraoperative Neuromonitoring in Thyroid Surgery N/A
Completed NCT00150033 - Health-Related Quality of Life for Thyroid Patients Phase 2
Not yet recruiting NCT04351945 - Endocrine Changes and Their Correction in Heart and Lung Transplant Recipients and Donors
Enrolling by invitation NCT04411290 - Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases
Completed NCT03469310 - Minimizing Narcotic Analgesics After Endocrine Surgery Phase 4
Completed NCT00106119 - Thyroid and Glucose and Energy Metabolism Phase 2
Recruiting NCT03037385 - Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT04943146 - An Assessment of Aspirin Plus Prednisone Treatment for Euthyroid Women With Thyroid Autoimmunity
Not yet recruiting NCT04108923 - Comparative Study Between Ligasure Versus Conventional Vessel Ligation in Thyroidectomy N/A
Completed NCT04406779 - The Frequency of Thyroid Diseases in Women With Breast Cancer
Recruiting NCT03777033 - Systematic Administration of Calcium and Vitamin D After Thyroidectomy N/A